| 9/13/2010 | HY | Market Commentary: B/E Aero, Inergy, Continental drive-bys lead $2.3 billion primary; new deals up in trading
|
| 6/11/2010 | BKCVHY | Moody's: Inverness unchanged
|
| 9/23/2009 | HY | New Issue: Inverness Medical sells $100 million tap of 7 7/8% notes due 2016 at 96.5 to yield 8.599%
|
| 9/23/2009 | HY | Market Commentary: New deals rule as Delta prices, also GeoEye, Nebraska Book, Inverness; Gaylord up on tender
|
| 9/22/2009 | BKCVHY | S&P assigns Inverness notes B-
|
| 9/22/2009 | BKCVHY | Moody's rates Inverness Medical notes B2
|
| 9/22/2009 | HY | Inverness Medical to price $100 million add-on to 7 7/8% notes due February 2016 on Wednesday
|
| 9/22/2009 | HY | Market Commentary: New bonds help tone; Sprint holds; Harrah's heads higher; QVC doubles deal to $1 billion
|
| 8/6/2009 | HY | Market Commentary: Affinia, Global Aviation deals price, Affinia trades up, other newbies also firm; funds see $689 million inflow
|
| 8/5/2009 | HY | Market Commentary: Upsized Iron Mountain deal prices, also Novelis, Inverness; earnings lift names in trading
|
| 8/5/2009 | BKCVHY | S&P rates Inverness Medical debt B-
|
| 8/5/2009 | HY | New Issue: Inverness Medical prices $150 million 6.5-year notes to yield 81/4%
|
| 8/4/2009 | HY | Inverness Medical to price $150 million 6.5-year notes on Wednesday
|
| 8/4/2009 | HY | Market Commentary: Novelis, Inverness slate deals for Wednesday pricing; ArvinMeritor up in mostly firm market
|
| 5/11/2009 | HY | Market Commentary: Range Resources, SandRidge price deals; market mostly down; Rite Aid off despite analyst boost
|
| 5/8/2009 | HY | Market Commentary: Primary pauses, but Ameristar slates; Goodyear, others off highs; buyers eye less known names
|
| 5/7/2009 | HY | New Issue: Inverness sells upsized $400 million 9% seven-year notes at 96.865 to yield 9 5/8%
|
| 5/7/2009 | HY | Market Commentary: Inverness, Owens-Brockway price upsized deals; new Goodyears firm; junk stays strong; funds gain $822 million
|
| 5/6/2009 | HY | Market Commentary: Upsized Goodyear, Nalco deals price; new Nalco firms, Teck rise continues; market tone strong
|
| 5/5/2009 | HY | Market Commentary: $4 billion Teck deal leads huge day, Host, Crown, Silgan also price; MGM zooms on Q1, remarks
|
| 5/4/2009 | BKCVHY | Moody's gives Inverness notes B3
|
| 5/4/2009 | BKCVHY | S&P gives Inverness notes B-
|
| 5/4/2009 | HY | Inverness Medical Innovations launches $200 million seven-year notes
|
| 5/4/2009 | HY | Market Commentary: Psychiatric Solutions prices deal; Sprint runs up on numbers; Liberty fails to lift DirecTV
|
| 4/27/2009 | BK | Market Commentary: GM rises on exchange offer; Michael Foods breaks; Early market emerges on UPC; Inverness up
|
| 4/13/2009 | CVHY | Inverness Medical Innovations files automatic shelf registration
|
| 4/6/2009 | BKCVHY | S&P: Inverness view positive
|
| 3/19/2009 | BKCVHY | Moody's lifts Inverness
|
| 3/19/2009 | CV | Inverness to pay April dividends on convertible preferreds in kind
|
| 6/19/2008 | BKCVHY | Moody's confirms Inverness
|
| 5/19/2008 | BKCVHY | S&P gives Inverness convertible preferreds CCC+
|
| 5/15/2008 | CV | Inverness sweetens conversion price of 3% convertibles due 2016 to $43.98
|
| 5/9/2008 | CV | Inverness Medical convertible preferred stock offers value relative to common: Lehman analysts
|
| 5/9/2008 | CV | Inverness issues about $720 million perpetual convertible preferreds for Matria merger
|
| 5/9/2008 | SS | Inverness Medical acquires Matria Healthcare for $143.9 million plus stock
|
| 5/8/2008 | SS | Market Commentary: Analyst says the time is right for DRS-Finmecanica merger, but regulatory approvals are not a slam dunk
|
| 5/8/2008 | SS | Shareholders OK Matria Healthcare's $280 million cash and stock deal with Inverness Medical
|
| 1/28/2008 | BKCVHY | S&P affirms Inverness
|
| 1/28/2008 | BKCVHY | Moody's may cut Inverness
|
| 1/28/2008 | SS | Inverness Medical continues acquisition strategy, announces definitive agreement with Matria
|
| 1/28/2008 | SS | Market Commentary: Nymex, CME confirm talks; ADS deal in doubt; Inverness buys up Matria; Landry's CEO loves company
|
| 12/12/2007 | SS | Inverness says it will continue current pace of acquiring companies
|
| 11/26/2007 | SS | Market Commentary: Tesoro shares dip on Tracinda rights plan concern; Inverness stock slips; Citigroup to make layoffs
|
| 11/19/2007 | SS | Market Commentary: Celgene, Pharmion to merge, sending shares of Pharmion up; Quanex stock spikes on merger, spinoff
|
| 11/14/2007 | BK | Market Commentary: Alltel, Chrysler widen OIDs; Inverness sets discount; VNU trades up; UAL, Delta seesaw on merger buzz
|
| 11/1/2007 | BK | Inverness seeks $100 million term loan add-on
|
| 10/24/2007 | SS | Market Commentary: Cablevision privatization rejected by shareholders; Inverness plans to buy Alere, stock off
|
| 10/3/2007 | SS | Market Commentary: Bear Stearns stock down on layoffs; Inverness stock up on Bio-Stat merger; Ness shares slip
|
| 10/2/2007 | SS | Waiting period ends for Inverness acquisition of HemoSense
|
| 9/13/2007 | SS | Market Commentary: Magna jumps on restructuring; Nucor gains on Nelson purchase; Inverness up after closing Cholestech deal
|
| 9/13/2007 | SS | Inverness expands cardiac monitoring capabilities with acquisition of Cholestech
|
| 8/29/2007 | SS | Market Commentary: Alltel climbs as shareholders OK LBO; Zimmer to buy Orthosoft; Whole Foods up after reaping Wild Oats
|
| 8/28/2007 | SS | Inverness to acquire Matritech in asset purchase agreement
|
| 8/28/2007 | SS | Market Commentary: PolyMedica stock up on Medco acquisition; Inverness to buy Matritech, shoving shares down
|
| 8/9/2007 | SS | Cholestech shareholders to decide Inverness merger on Sept. 12
|
| 8/7/2007 | SS | Inverness adds HemoSense to list of acquisitions
|
| 8/7/2007 | SS | Market Commentary: Luminent tumbles hard; Countrywide rallies; consolidation in medical diagnostics; markets jagged
|
| 7/25/2007 | SS | Inverness, Cholestech clear waiting period hurdle in stock-for-stock exchange merger
|
| 6/29/2007 | SS | Inverness completes acquisition of Biosite
|
| 6/26/2007 | SS | Market Commentary: Huntsman pressures Lyondell, lifts KMG; Ventana pushes Cepheid; BCE off; Vonage up
|
| 6/26/2007 | BK | Market Commentary: U.S. Foodservice shelved; Chrysler Financial, Atlas, Vistar set talk; Inverness, Concentra, Viant break
|
| 6/26/2007 | HY | Inverness Medical accepts tenders for all 83/4% notes due 2012
|
| 6/26/2007 | SS | Inverness completes tender offer for Biosite, subsequent offer begins
|
| 6/21/2007 | BK | Market Commentary: U.S. Foodservice, Trilogy tweak deals; Harlan, Norwood set talk; Tribune rebounds with market
|
| 6/19/2007 | BKCVHY | S&P affirms Inverness Medical, gives loans BB, B-
|
| 6/18/2007 | BKCVHY | Moody's rates Inverness loans B1, Caa1
|
| 6/12/2007 | HY | Inverness Medical gets consents, sets pricing for 83/4% notes
|
| 6/8/2007 | BK | Market Commentary: Inverness sets second-lien talk; Varietal, Hercules talk emerges; NRG Energy, Conseco break
|
| 6/7/2007 | SS | Inverness Medical, Biosite merger clears waiting period hurdle
|
| 6/6/2007 | BKHY | Inverness moves upsized $1.25 billion credit facility launch to Friday, cancels bonds
|
| 6/4/2007 | SS | Inverness Medical, Cholestech to merge in stock exchange deal
|
| 5/29/2007 | BK | Inverness $1 billion credit facility now set to launch on June 7
|
| 5/29/2007 | HY | Inverness Medical seeks tenders, consents for 83/4% notes
|
| 5/21/2007 | BKCVHY | S&P keeps Inverness on watch, rates convertibles B-
|
| 5/18/2007 | BK | Inverness to launch $1.3 billion facility on June 6
|
| 5/17/2007 | SS | Inverness to acquire Biosite for $92.50 per share in cash tender offer
|
| 5/15/2007 | CVPP | New Issue: Inverness sells upsized $150 million of 10-year convertibles to yield 3%, up 30%
|
| 5/15/2007 | SS | Biosite: Latest offer from Inverness superior, Beckman Coulter will not go higher than $90 per share
|
| 5/15/2007 | SS | Market Commentary: Dow Jones better, Reuters rises; SunTrust lower; 21st Century up; Ingersoll-Rand gains; Biosite off
|
| 5/10/2007 | CV | Market Commentary: Amgen falls under drug panel scrutiny; Alesco, Chesapeake gain early, end flat; CACI, L-1 quiet in gray
|
| 5/10/2007 | SS | Biosite says Inverness' latest proposal could be superior to Beckman Coulter deal
|
| 5/10/2007 | SS | Market Commentary: Magna rises; Hillenbrand split cheered; Griffon seen breaking up; Back Yard Burgers bounces
|
| 5/10/2007 | BKHY | Inverness revised commitments for Biosite bid call for $317.5 million bonds, $1.3 billion facility
|
| 5/10/2007 | CV | Inverness sells $132.5 million 10-year convertibles to yield 3%, up 30%
|
| 5/9/2007 | CV | Inverness prices $132.5 million convertibles at 3%, up 30%
|
| 5/9/2007 | SS | Inverness raises offer for Biosite to $92.50
|
| 5/2/2007 | SS | Beckman Coulter amends Biosite agreement; on par with Inverness Medical offer
|
| 4/26/2007 | BKHY | Moody's may lower Inverness
|
| 4/26/2007 | SS | Biosite to move forward with superior proposal from Inverness; Beckman-Coulter can counter
|
| 4/26/2007 | SS | Market Commentary: Nacco oscillates; Wendy's gains; Applebee's rises; Biosite bows; Harman up; new Delta slow, low
|
| 4/20/2007 | SS | Biosite to evaluate revised financing commitment letters from Inverness; Beckman Coulter deal continues
|
| 4/20/2007 | SS | Market Commentary: Clear Channel off; H&R Block up; Aeroflex rises; Genesco, Foot Locker gain; SLM slides
|
| 4/18/2007 | SS | Biosite to review revisions from Inverness Medical as Beckman Coulter tender offer continues
|
| 4/17/2007 | SS | Waiting period expires in Beckman Coulter's acquisition of Biosite; transaction slated to close in May
|
| 4/10/2007 | BKHY | S&P puts Inverness on watch
|
| 4/10/2007 | SS | Biosite to enter discussions with Inverness Medical; Beckman Coulter tender offer continues
|
| 4/9/2007 | SS | Inverness Medical: Biosite fails to respond to $90-per-share acquisition proposal
|
| 4/9/2007 | SS | Market Commentary: Mirant boosts power producers; Dow Chemical, Devon higher; Herbalife slides; Affordable up
|
| 4/5/2007 | BKHY | Inverness bid for Biosite backed by $1.3 billion facility commitment, $450 million bonds
|
| 4/5/2007 | SS | Biosite receives unsolicited offer from Inverness Medical as Beckman Coulter deal moves forward
|
| 4/5/2007 | SS | Market Commentary: Biosite boosted by rival bid; DaimlerChrysler driven up; Conseco climbs; Calpine rises
|
| 3/21/2007 | BKHY | S&P ups Inverness Medical
|
| 1/19/2007 | BK | Inverness to repay some term debt with common stock proceeds
|
| 11/22/2006 | CVHY | Inverness Medical Innovations files stock, warrant shelf
|
| 11/2/2006 | BT | S&P: Inverness Medical on positive watch
|
| 10/11/2006 | BKBTHY | Moody's ups Inverness
|
| 8/22/2006 | PP | Market Commentary: Advanced Cell Technology's stock jumps by 53% on PIPE; Foldera raises $4.3 million from stock deal
|
| 8/21/2006 | PP | Market Commentary: Inverness secures $151.25 million from stock offering; Oscient, unit completes private placements
|
| 8/21/2006 | BTPP | New Issue: Inverness Medical secures $151.3 million from sale of stock
|
| 8/21/2006 | BT | Market Commentary: Dynavax says flu vaccine effective on divergent viral strains; Inverness to wrap $151.25 million PIPE
|
| 7/18/2006 | BT | Inverness, P&G to develop consumer diagnostic products
|
| 6/13/2006 | BT | Inverness lays off 20 employees
|
| 5/22/2006 | BT | Inverness Medical to close Applied Biotech, Scandinavian Micro Biodevices subsidiaries
|
| 5/18/2006 | BT | Inverness acquires manufacturing facility in China for $20 million
|
| 5/18/2006 | BT | Inverness Medical to acquire minority interest in TechLab
|
| 4/5/2006 | BKBT | Inverness amends facility, adding new term loan, tweaking revolver tranche sizes
|
| 3/1/2006 | BT | Inverness Medical agrees to acquire Clondiag chip technologies for cash, stock
|
| 2/24/2006 | BT | Inverness to acquire ACON business unit for $175 million in cash, stock deal, settles patent suit
|
| 2/7/2006 | BTPP | New Issue: Inverness Medical Innovations prices $83 million stock sale
|
| 12/22/2005 | BT | Inverness receives FDA marketing clearance for chest pain diagnostic
|
| 12/19/2005 | BT | Inverness gets 510(K) clearance for BinaxNOW diagnostic test to include avian flu
|
| 12/16/2005 | BT | Inverness Medical Innovations says SEC investigating revenue recognition matter
|
| 12/1/2005 | BT | Leerink initiates Inverness at market perform
|
| 10/3/2005 | BT | Inverness acquires two diagnostic device companies
|
| 9/29/2005 | BT | Innogenetics sells affiliate to Inverness Medical for €15.5 million
|
| 8/2/2005 | PP | Market Commentary: PIPE volume improving; PanAmerican Bancorp raises $17.4 million
|
| 8/1/2005 | BTPP | New Issue: Inverness Medical secures $95 million from private placement of stock
|
| 8/1/2005 | BK | Inverness to repay bank debt with stock proceeds
|
| 8/1/2005 | PP | Market Commentary: Inverness secures $95 million from stock deal; PIPE volume suffers from earnings
|
| 7/7/2005 | BKBT | Inverness gets $100 million amended and restated credit facility
|
| 7/5/2005 | HY | Moody's drops Inverness Medical
|
| 10/21/2004 | BK | Inverness uses revolver borrowings to repay and terminate subsidiary's loan
|
| 2/6/2004 | HY | Market Commentary: Pegasus wings clipped by DirecTV; Affinity, Pliant, Ormat deals price
|
| 2/5/2004 | HY | Inverness Medical Innovations $150 million eight-year notes yield 83/4%
|
| 2/5/2004 | HY | Market Commentary: Argosy, upsized Ply Gem price; Level 3 dives on outlook; funds break streak, lose $1.57 billion
|
| 2/4/2004 | HY | Inverness Medical Innovations $150 million eight-year notes price talk 83/4%-9%
|
| 2/4/2004 | HY | Market Commentary: Playtex prices upsized issue; Owens-Illinois lower after downgrade
|
| 1/26/2004 | HY | S&P rates Inverness notes B-
|
| 1/22/2004 | HY | Inverness Medical Innovations to start roadshow Tuesday for $150 million eight-year notes
|
